We are live on ! Find out more
ETTX

Entasis Therapeutics Holdings Inc.
ETTX

Delisted

ETTX was delisted on the 8th of July, 2022.

Back to rankings

29 hedge funds and large institutions have $11.3M invested in Entasis Therapeutics Holdings Inc. in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 7

27% more capital invested

Capital invested by funds: $8.89M → $11.3M (+$2.43M)

21% more funds holding

Funds holding: 24 → 29 (+5)

Holders
29
Holders Change
+5
Holders Change %
+20.83%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
9
Reduced
7
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Two Sigma Advisers
Two Sigma Advisers
New York
+$179K
2
Jane Street
Jane Street
New York
+$87.3K
3
VF
Virtu Financial
New York
+$85.8K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$70.7K
5
Two Sigma Investments
Two Sigma Investments
New York
+$59.7K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$214K
2
AIMCA
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
-$176K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$30.6K
4
BlackRock
BlackRock
New York
-$16.7K
5
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
-$2.41K
Name Holding Trade Value Shares
Change 		Change in
Stake
TGHSA
1
TPG Group Holdings (SBS) Advisors
Texas
$3.41M – – –
EAM
2
Eventide Asset Management
Massachusetts
$1.97M – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.42M +$16.9K +6,238 +1%
Renaissance Technologies
4
Renaissance Technologies
New York
$1.04M -$214K -79,084 -20%
Two Sigma Advisers
5
Two Sigma Advisers
New York
$765K +$179K +66,058 +41%
Two Sigma Investments
6
Two Sigma Investments
New York
$622K +$59.7K +22,001 +13%
BCM
7
Bridgeway Capital Management
Texas
$367K – – –
Geode Capital Management
8
Geode Capital Management
Massachusetts
$311K +$32.7K +12,047 +15%
Janney Montgomery Scott
9
Janney Montgomery Scott
Pennsylvania
$229K -$2.41K -890 -1%
AIMCA
10
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$217K -$176K -65,000 -50%
State Street
11
State Street
Massachusetts
$135K +$2.98K +1,100 +3%
Jane Street
12
Jane Street
New York
$107K +$87.3K +32,177 New
VF
13
Virtu Financial
New York
$106K +$85.8K +31,631 New
BlackRock
14
BlackRock
New York
$89K -$16.7K -6,144 -19%
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$87K +$70.7K +26,070 New
Northern Trust
16
Northern Trust
Illinois
$86K +$13.1K +4,839 +23%
OQS
17
Occudo Quantitative Strategies
Florida
$75K -$1.63K -601 -3%
SFI
18
Susquehanna Fundamental Investments
Pennsylvania
$71K -$1.9K -700 -3%
Acadian Asset Management
19
Acadian Asset Management
Massachusetts
$68K -$30.6K -11,277 -35%
TRCT
20
Tower Research Capital (TRC)
New York
$50K +$40.9K +15,093 New
JIP
21
Jaffetilchin Investment Partners
Florida
$37K – – –
UBS Group
22
UBS Group
Switzerland
$18K +$14.1K +5,207 +5,055%
SWM
23
Spire Wealth Management
Virginia
$13K – – –
Osaic Holdings
24
Osaic Holdings
Arizona
$7K – – –
BG
25
Bollard Group
Massachusetts
$5K – – –
1
2

ETTX Hedge Fund Activity: Q3 2021 in Review

29 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Entasis Therapeutics Holdings Inc. (ETTX) for Q3 2021, worth a combined $11.3M — up 27% from $8.89M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ETTX positions and 0 closed out — a net gain of 5 holders — while 9 added to existing stakes and 7 trimmed.

The largest buyer was Two Sigma Advisers, adding an estimated $179K. The largest seller was Renaissance Technologies, cutting an estimated $214K.

  • 29 institutional investors held Entasis Therapeutics Holdings Inc. (ETTX) as of Q3 2021, up from 24 in Q2 2021.
  • Funds reported $11.3M of Entasis Therapeutics Holdings Inc. stock for Q3 2021, up 27% quarter-over-quarter.
  • 5 funds opened new Entasis Therapeutics Holdings Inc. positions in Q3 2021 and 0 closed out, a net change of +5 holders.
  • The largest Entasis Therapeutics Holdings Inc. buyer in Q3 2021 was Two Sigma Advisers, an estimated $179K added.
  • The largest Entasis Therapeutics Holdings Inc. seller in Q3 2021 was Renaissance Technologies, an estimated $214K sold.

Based on aggregated 13F filings for Q3 2021.